INSULET CORPORATION Revenue by Geography
No Revenue by Geography for PODD on this site yet.
- 2025-12-31: Others Not split by product in the filing$2.71B100.00%; Total revenue $2.71B.
- 2024-12-31: Others Not split by product in the filing$2.07B100.00%; Total revenue $2.07B.
- 2023-12-31: Others Not split by product in the filing$1.70B100.00%; Total revenue $1.70B.
- 2022-12-31: Others Not split by product in the filing$1.06B100.00%; Total revenue $1.06B.
Source checked: the stored Revenue by Geography page for PODD.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $2.71B 100.00% | $2.71B |
| 2024-12-31 | Not split by product in the filing $2.07B 100.00% | $2.07B |
| 2023-12-31 | Not split by product in the filing $1.70B 100.00% | $1.70B |
| 2022-12-31 | Not split by product in the filing $1.06B 100.00% | $1.06B |
| 2021-12-31 | Not split by product in the filing $1.04B 100.00% | $1.04B |
| 2020-12-31 | Not split by product in the filing $904.40M 100.00% | $904.40M |
| 2019-12-31 | Not split by product in the filing $738.20M 100.00% | $738.20M |
| 2018-12-31 | Not split by product in the filing $563.80M 100.00% | $563.80M |
| 2017-12-31 | Not split by product in the filing $463.80M 100.00% | $463.80M |
| 2016-12-31 | Not split by product in the filing $366.99M 100.00% | $366.99M |
| 2015-12-31 | Not split by product in the filing $263.89M 100.00% | $263.89M |
| 2014-12-31 | Not split by product in the filing $231.32M 100.00% | $231.32M |
| 2013-12-31 | Not split by product in the filing $185.14M 100.00% | $185.14M |
| 2012-12-31 | Not split by product in the filing $211.37M 100.00% | $211.37M |
| 2011-12-31 | Not split by product in the filing $152.25M 100.00% | $152.25M |
| 2010-12-31 | Not split by product in the filing $96.97M 100.00% | $96.97M |
| 2009-12-31 | Not split by product in the filing $66.03M 100.00% | $66.03M |
Each quarter (3 month)
| Quarter end | Product, Omnipod | Drug Delivery | Others | Total revenue |
|---|---|---|---|---|
| 2026-06-30 | $795.90M 99.28% | $5.80M 0.72% | $801.70M | |
| 2026-03-31 | Not split by product $761.70M 100.00% | $761.70M | ||
| 2025-12-31 | Not split by product $783.80M 100.00% | $783.80M | ||
| 2025-09-30 | Not split by product $706.30M 100.00% | $706.30M | ||
| 2025-06-30 | $639.00M 98.44% | $10.20M 1.57% | $649.10M | |
| 2025-03-31 | Not split by product $569.00M 100.00% | $569.00M | ||
| 2024-12-31 | Not split by product $597.50M 100.00% | $597.50M | ||
| 2024-09-30 | Not split by product $543.90M 100.00% | $543.90M | ||
| 2024-06-30 | Not split by product $488.50M 100.00% | $488.50M | ||
| 2024-03-31 | Not split by product $441.70M 100.00% | $441.70M | ||
| 2023-12-31 | Not split by product $509.80M 100.00% | $509.80M | ||
| 2023-09-30 | Not split by product $432.70M 100.00% | $432.70M | ||
| 2023-06-30 | Not split by product $396.50M 100.00% | $396.50M | ||
| 2023-03-31 | Not split by product $261.30M 100.00% | $261.30M | ||
| 2022-12-31 | Not split by product $282.60M 100.00% | $282.60M | ||
| 2022-09-30 | Not split by product $281.90M 100.00% | $281.90M | ||
| 2022-06-30 | Not split by product $243.90M 100.00% | $243.90M | ||
| 2022-03-31 | Not split by product $247.00M 100.00% | $247.00M | ||
| 2021-12-31 | Not split by product $268.80M 100.00% | $268.80M | ||
| 2021-09-30 | Not split by product $261.80M 100.00% | $261.80M | ||
| 2021-06-30 | Not split by product $259.90M 100.00% | $259.90M | ||
| 2021-03-31 | Not split by product $249.50M 100.00% | $249.50M | ||
| 2020-12-31 | Not split by product $246.10M 100.00% | $246.10M | ||
| 2020-09-30 | Not split by product $234.00M 100.00% | $234.00M | ||
| 2020-06-30 | Not split by product $226.30M 100.00% | $226.30M | ||
| 2020-03-31 | Not split by product $198.00M 100.00% | $198.00M | ||
| 2019-12-31 | Not split by product $209.40M 100.00% | $209.40M | ||
| 2019-09-30 | Not split by product $192.10M 100.00% | $192.10M | ||
| 2019-06-30 | Not split by product $177.10M 100.00% | $177.10M | ||
| 2019-03-31 | Not split by product $159.60M 100.00% | $159.60M | ||
| 2018-12-31 | Not split by product $164.90M 100.00% | $164.90M | ||
| 2018-09-30 | Not split by product $151.10M 100.00% | $151.10M | ||
| 2018-06-30 | Not split by product $124.20M 100.00% | $124.20M | ||
| 2018-03-31 | Not split by product $123.60M 100.00% | $123.60M | ||
| 2017-12-31 | Not split by product $130.52M 100.00% | $130.52M | ||
| 2017-09-30 | Not split by product $121.78M 100.00% | $121.78M | ||
| 2017-06-30 | Not split by product $109.76M 100.00% | $109.76M | ||
| 2017-03-31 | Not split by product $101.71M 100.00% | $101.71M | ||
| 2016-12-31 | Not split by product $103.58M 100.00% | $103.58M | ||
| 2016-09-30 | Not split by product $94.87M 100.00% | $94.87M | ||
| 2016-06-30 | Not split by product $87.33M 100.00% | $87.33M | ||
| 2016-03-31 | Not split by product $81.21M 100.00% | $81.21M | ||
| 2015-12-31 | Not split by product $83.80M 100.00% | $83.80M | ||
| 2015-09-30 | Not split by product $71.39M 100.00% | $71.39M | ||
| 2015-06-30 | Not split by product $60.55M 100.00% | $60.55M | ||
| 2015-03-31 | Not split by product $48.15M 100.00% | $48.15M | ||
| 2014-12-31 | Not split by product $58.36M 100.00% | $58.36M | ||
| 2014-09-30 | Not split by product $60.03M 100.00% | $60.03M | ||
| 2014-06-30 | Not split by product $57.58M 100.00% | $57.58M | ||
| 2014-03-31 | Not split by product $55.35M 100.00% | $55.35M | ||
| 2013-12-31 | Not split by product $68.53M 100.00% | $68.53M | ||
| 2013-09-30 | Not split by product $61.10M 100.00% | $61.10M | ||
| 2013-06-30 | Not split by product $60.09M 100.00% | $60.09M | ||
| 2013-03-31 | Not split by product $57.36M 100.00% | $57.36M | ||
| 2012-12-31 | Not split by product $57.83M 100.00% | $57.83M | ||
| 2012-09-30 | Not split by product $54.75M 100.00% | $54.75M | ||
| 2012-06-30 | Not split by product $51.03M 100.00% | $51.03M | ||
| 2012-03-31 | Not split by product $47.75M 100.00% | $47.75M | ||
| 2011-12-31 | Not split by product $47.19M 100.00% | $47.19M | ||
| 2011-09-30 | Not split by product $44.59M 100.00% | $44.59M | ||
| 2011-06-30 | Not split by product $32.21M 100.00% | $32.21M | ||
| 2011-03-31 | Not split by product $28.26M 100.00% | $28.26M | ||
| 2010-12-31 | Not split by product $27.77M 100.00% | $27.77M | ||
| 2010-09-30 | Not split by product $25.45M 100.00% | $25.45M | ||
| 2010-06-30 | Not split by product $22.94M 100.00% | $22.94M | ||
| 2010-03-31 | Not split by product $20.81M 100.00% | $20.81M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |